Immix Biopharma, Inc.
IMMX
$10.97
$0.050.46%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 232.11M | 90.58M | 100.41M | 15.95M | 11.64M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.40M | 1.36M | 677.60K | 504.20K | 549.80K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 279.20K | 335.70K | 150.70K | 132.80K | 137.70K |
| Total Current Assets | 233.79M | 92.27M | 101.24M | 16.58M | 12.33M |
|
|
|||||
| Total Current Assets | 233.79M | 92.27M | 101.24M | 16.58M | 12.33M |
| Net Property, Plant & Equipment | 3.25M | 3.36M | 3.49M | 3.36M | 3.18M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 20.40K | 185.10K | 114.00K | 132.10K | 131.00K |
| Total Assets | 239.11M | 95.82M | 104.84M | 20.08M | 15.64M |
|
|
|||||
| Total Accounts Payable | 5.28M | 4.73M | 5.44M | 7.05M | 6.61M |
| Total Accrued Expenses | 3.91M | 5.68M | 4.53M | 3.66M | 3.32M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 111.10K | 125.40K | 139.30K | 141.30K | 70.50K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 9.30M | 10.54M | 10.11M | 10.85M | 10.01M |
|
|
|||||
| Total Current Liabilities | 9.30M | 10.54M | 10.11M | 10.85M | 10.01M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 890.60K | 912.30K | 933.60K | 965.10K | 972.30K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 10.19M | 11.45M | 11.04M | 11.82M | 10.98M |
|
|
|||||
| Common Stock & APIC | 355.00M | 198.91M | 198.30M | 102.08M | 90.88M |
| Retained Earnings | -126.11M | -114.55M | -104.46M | -93.78M | -86.19M |
| Treasury Stock & Other | 18.80K | 5.70K | -39.80K | -37.50K | -34.90K |
| Total Common Equity | 228.92M | 84.36M | 93.80M | 8.27M | 4.65M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 228.92M | 84.36M | 93.80M | 8.27M | 4.65M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 228.92M | 84.36M | 93.80M | 8.27M | 4.65M |
|
|
|||||